Inactief instrument

Andere talen Iovance Biotherapeutics Inc Nasdaq

Aandelen

US53619R1023

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Small lymphocytic lymphoma Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)	14/05
Iovance Biotherapeutics' Patient Selection for Amtagvi Launch Minimizing Attrition, Truist Securities Says	10/05
Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates	10/05
Iovance Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Iovance Biotherapeutics Q1 Loss Narrows -- Shares Higher After Hours	09/05
Iovance Biotherapeutics: Q1 Earnings Snapshot	09/05
Earnings Flash (IOVA) IOVANCE BIOTHERAPEUTICS Posts Q1 Revenue $715,000	09/05
Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates	09/05
Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024	01/05
Iovance Biotherapeutics to Present at Upcoming Conferences	30/04
Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting	24/04
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(4) - April 19, 2024	22/04
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	19/04
General (Ret.) Merrill A. McPeak, Member of the Board of Directors of Iovance Biotherapeutics, Inc. Retires and Not Stands for Re-Election	29/03
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(4)	25/03
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	22/03
Iovance Biotherapeutics to Present at Upcoming Conferences	04/03
Sector Update: Health Care Stocks Lean Lower Pre-Bell Monday	04/03
Iovance Biotherapeutics Says FDA Lifts Partial Clinical Hold on Lung Cancer Study	04/03
Iovance Biotherapeutics Syas FDA Lifts Partial Clinical Hold on LN-145	04/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Iovance Biotherapeutics Inc Nasdaq

Aandelen

US53619R1023

Andere talen

Filters